Yin Hongzhang, the former deputy director of the administration's drug testing centre, received a 10-year sentence and was fined 500,000 yuan for taking bribes to help vaccine manufacturers gain approval for their drugs, China's Legal Evening News newspaper said.
His wife and son earlier received prison sentences for participating in the scheme and accepting property and bribes worth 3.56 million yuan (USD 510,000), including ivory products worth 180,000 yuan, it said.
The sentence follows the March revelation of a massive vaccine scandal that enraged the Chinese public.
That case involved the improper storage, transport and sale of tens of millions of dollars' worth of vaccines -- many of them expired.
No one was believed to have been harmed, but the story still provoked outrage in a country where families, who were long limited to one child by government policy, fiercely protect their offspring.
From 2010, the pair, a mother and daughter from Shandong province in eastern China, sold 25 different kinds of expired or improperly stored vaccines worth more than 570 million yuan (USD 88 million), the official Xinhua news agency reported at the time.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
